INSTRUMENTS |
|
The following instruments have been donated by Photonic Pharma to the University of Minnesota (UMN), effective March 31, 2026. The instruments continue to be available to users at the Biophysical Technology Center at (UMN) as of April 1, 2026.
|
Equipment:
|
Fluorescence Lifetime plate reader (FLT-PR) for High-Throughput Screening (HTS)
Spectral Unmixing plate reader (SUPR)
|
|
Location:
|
Room 1-150, Nils Hasselmo Hall
University of Minnesota 312 Church Street SE Minneapolis, MN 55455 |
|
Reservations:
|
DISCLOSURE OF CONFLICT OF INTEREST
Visit here for the Disclosure to University of Minnesota users. A summary is below.
Dr. Thomas, in addition to his faculty position at UMN, holds an executive position with Photonic Pharma LLC and, along with Jennifer J. Thomas, hold a majority interest in Photonic Pharma. As a result, a Conflict of Interest Management Plan (COIMP) has been in place for Dr. Thomas under the direction of BMBB Department Head and the supervision of the UMN Office of Institutional Compliance, Conflict of Interest Program. (The University of Minnesota holds a minority interest in Photonic Pharma under the terms of an Exclusive Patent License.)
Visit here for the Disclosure to University of Minnesota users. A summary is below.
Dr. Thomas, in addition to his faculty position at UMN, holds an executive position with Photonic Pharma LLC and, along with Jennifer J. Thomas, hold a majority interest in Photonic Pharma. As a result, a Conflict of Interest Management Plan (COIMP) has been in place for Dr. Thomas under the direction of BMBB Department Head and the supervision of the UMN Office of Institutional Compliance, Conflict of Interest Program. (The University of Minnesota holds a minority interest in Photonic Pharma under the terms of an Exclusive Patent License.)